Elliot Ehrich, EVP, R&D & CMO, Alkermes, Inc at Alkermes plc. (ALKS), sold 25,000 shares at $62.66 ($1.6M) on 2015-04-21, disclosed to the SEC on 2015-04-23.
Scheduled sale ($1.6M) by EVP, R&D & CMO, Alkermes, Inc under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.99 | 10,228 | $634K | 40.7% |
| 2 | $62.66 | 14,772 | $926K | 59.3% |
| Total | $62.39 avg | 25,000 | $1.6M | 100% |
| Filing → |
| ALKS | SELL | 2017-02-16 | $1.2M | — | Filing → |
| ALKS | SELL | 2017-01-18 | $1.3M | — | Filing → |
| ALKS | SELL | 2017-01-06 | $618K | — | Filing → |